Trial Profile
Evaluation of a Three-Dose Basiliximab Induction Immunosuppression Regimen in Adult Heart Transplant Recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Aug 2015
Price :
$35
*
At a glance
- Drugs Basiliximab (Primary)
- Indications Heart transplant rejection
- Focus Therapeutic Use
- 20 Aug 2015 New trial record